Home
About
Overview
Sharing Data
ORCID
Help
History (15)
Efficacy of Vedolizumab Induction and Maintenance Therapy in Patients With Ulcerative Colitis, Regardless of Prior Exposure to Tumor Necrosis Factor Antagonists.
Equal access to health care does not eliminate disparities in the management of adults with appendicitis.
A haplotype-based framework for group-wise transmission/disequilibrium tests for rare variant association analysis.
A SENSITIVE METHOD FOR INTERFERON ASSAY.
MLL3 is a haploinsufficient 7q tumor suppressor in acute myeloid leukemia.
See All 15 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
MLL3 is a haploinsufficient 7q tumor suppressor in acute myeloid leukemia.
MLL3 is a haploinsufficient 7q tumor suppressor in acute myeloid leukemia. Cancer Cell. 2014 May 12; 25(5):652-65.
View in:
PubMed
subject areas
Animals
Azepines
Cell Differentiation
Cell Transformation, Neoplastic
Chromosome Deletion
Chromosomes, Human, Pair 7
Clustered Regularly Interspaced Short Palindromic Repeats
Drug Resistance, Neoplasm
Gene Dosage
Haploinsufficiency
Histone-Lysine N-Methyltransferase
Humans
Leukemia, Myeloid, Acute
Mice
Mice, Inbred C57BL
Myeloid-Lymphoid Leukemia Protein
RNA Interference
RNA, Small Interfering
Triazoles
Tumor Suppressor Proteins
authors with profiles
Wendy Stock
Michelle M. Lebeau